North America Migraine Drugs Market Size & Outlook

The migraine drugs market in North America is expected to reach a projected revenue of US$ 5,168.1 million by 2030. A compound annual growth rate of 12.2% is expected of North America migraine drugs market from 2024 to 2030.
Revenue, 2023 (US$M)
$2,306.3
Forecast, 2030 (US$M)
$5,168.1
CAGR, 2024 - 2030
12.2%
Report Coverage
North America

North America migraine drugs market highlights

  • The North America migraine drugs market generated a revenue of USD 2,306.3 million in 2023.
  • The market is expected to grow at a CAGR of 12.2% from 2024 to 2030.
  • In terms of segment, acute was the largest revenue generating treatment in 2023.
  • Preventive is the most lucrative treatment segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 2,306.3 million
Market revenue in 2030USD 5,168.1 million
Growth rate12.2% (CAGR from 2023 to 2030)
Largest segmentAcute
Fastest growing segmentPreventive
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAcute, Preventive
Key market players worldwideGlaxoSmithKline, Pfizer Inc, AbbVie Inc, Amgen Inc, Eli Lilly and Co, Teva Pharmaceutical Industries Ltd, Biohaven Ltd, Johnson & Johnson, Bausch Health Companies Inc


Other key industry trends

  • In terms of revenue, North America region accounted for 40.9% of the global migraine drugs market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,240.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Migraine Drugs Market Companies

Name Profile # Employees HQ Website

North America migraine drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to migraine drugs market will help companies and investors design strategic landscapes.


Acute was the largest segment with a revenue share of 63.31% in 2023. Horizon Databook has segmented the North America migraine drugs market based on acute, preventive covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America migraine drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America migraine drugs market databook

  • Our clientele includes a mix of migraine drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America migraine drugs market , including forecasts for subscribers. This continent databook contains high-level insights into North America migraine drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America migraine drugs market size, by country, 2018-2030 (US$M)

North America Migraine Drugs Market Outlook Share, 2023 & 2030 (US$M)

North America migraine drugs market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more